# Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019

> **NCT04338009** · NA · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 152 (actual)

## Conditions studied

- COVID-19

## Interventions

- **OTHER:** Discontinuation of ARB/ACEI
- **OTHER:** Continuation of ARB/ACEI

## Key facts

- **NCT ID:** NCT04338009
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-31
- **Primary completion:** 2020-08-20
- **Final completion:** 2020-08-20
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2021-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04338009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04338009, "Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04338009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*